Spyre Therapeutics, Inc. (SYRE)

71.25 -2.14 (-2.92%) USD  |  NASDAQ  |  Apr 21, 16:00
71.00 -0.25 (-0.35%) After-Hours: 19:33
More

Spyre Therapeutics Operating Income (TTM)

Operating Income (TTM) Chart

View Operating Income (TTM) for SYRE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Operating Income (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Operating Income (TTM) Range, Past 5 Years

View Operating Income (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Operating Income (TTM) Benchmarks

View Operating Income (TTM) Benchmarks
Start Trial
Tyra Biosciences, Inc. Upgrade
Replimune Group, Inc. Upgrade
Savara, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
Agios Pharmaceuticals, Inc. Upgrade